Xue, Yan
Wang, Qian
Zhao, Hongyu
Pan, Ren
Xia, Yanfei
Wang, Hongmei
Qin, Xiarong
Funding for this research was provided by:
Science and Technology Programme for Traditional Chinese Medicine of Zhejiang Province (2024ZL224)
Article History
Received: 16 January 2024
Accepted: 14 March 2024
First Online: 19 March 2024
Declarations
:
: The study was designed as a single-centre, prospective, double-blind, randomised controlled trial that followed the ethical standards stated in the Declaration of Helsinki and the Consolidated Standards of Reporting Trials (CONSORT) reporting guidelines. It was approved by the Ethics Committee of Zhejiang Hospital (Pro-review No. 47 K, 2022) and registered with the China Clinical Trial Registry (ChiCTR2300078425, 07/12/2023). All participants provided written informed consent before enrolment.
: Not applicable.
: The authors declare no competing interests.